title: Aldosterone and the kidney.
abstract: The mineralocorticoid aldosterone is a key regulator of blood pressure, fluid and electrolyte homeostasis, and acts via the mineralocorticoid receptor (MR). In recent years, an increasing number of studies revealed deleterious effects of aldosterone via its receptor. Especially in patients with primary hyperaldosteronism (PHA) a significant higher risk of developing cardiovascular comorbidities and comortalities was reported. Also renal insufficiency is clearly increased in patients with PHA indicating a role of aldosterone and the MR in the pathogenesis of renal injury. It has been shown that aldosterone in combination with an elevated salt intake, leads to renal inflammation, fibrosis, podocyte injury, and mesangial cell proliferation. This review focuses on the current knowledge of aldosterone effects in the kidney and highlights this topic from 2 perspectives: from clinical medicine and from experimental studies.
authors.affiliation: Department of Clinical Endocrinology, Charité Campus Mitte, Charité University Medicine Berlin, Berlin, Germany.
authors.forename: V G
authors.initials: VG
authors.lastname: Fourkiotis
authors.forename: G
authors.initials: G
authors.lastname: Hanslik
authors.forename: F
authors.initials: F
authors.lastname: Hanusch
authors.forename: J
authors.initials: J
authors.lastname: Lepenies
authors.forename: M
authors.initials: M
authors.lastname: Quinkler
mesh_terms: D000450:Aldosterone / Q000378:metabolism*; D000818:Animals; D006801:Humans; D006929:Hyperaldosteronism / Q000235:genetics / Q000378:metabolism*; D007668:Kidney / Q000378:metabolism*; D007674:Kidney Diseases / Q000235:genetics / Q000378:metabolism*; D018161:Receptors, Mineralocorticoid / Q000235:genetics / Q000378:metabolism
chemical_list: D018161:Receptors, Mineralocorticoid; D000450:Aldosterone